Company · Mont St-Hilaire, Quebec, Canada
Axcan Pharma Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 16
- 0 authorized now
- Natural health products
- 5
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 23
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ADEKS - DPSStatus since Oct 2007 | 02139650 | Cancelled Post Market | |
| ADEKS TABLETSStatus since Apr 2011 | 02031388 | Cancelled Post Market | |
| AMPHOJEL 500 SUSPENSIONStatus since Aug 1997 | 02125854 | Cancelled Post Market | |
| AMPHOJEL PLUS SUSPENSIONStatus since Jul 1998 | 02125005 | Cancelled Post Market | |
| AMPHOJEL PLUS TABLETSStatus since Jul 1998 | 02124998 | Cancelled Post Market | |
| COPTIN ORAL SUSPENSIONStatus since Sep 2006 | 00745618 | Cancelled Post Market | |
| COPTIN TABStatus since Sep 2006 | 00656933 | Cancelled Post Market | |
| DIGESS 8000 - CAPStatus since Aug 1997 | 02112744 | Cancelled Post Market | |
| ENDOSPRAYStatus since Sep 2002 | 02155451 | Cancelled Post Market | |
| MODULON INJ 50MG/5MLStatus since Jan 2000 | 00587850 | Cancelled Post Market | |
| MODULON TAB 100MGStatus since Aug 2002 | 00587869 | Cancelled Post Market | |
| RECTOVALONE 250MG/100MLStatus since Jul 1998 | 00609110 | Cancelled Post Market | |
| SALOFALK (R) 5-ASA ENTERIC COATED TAB- 250MGStatus since Aug 1998 | 02112779 | Cancelled Post Market | |
| SALOFALK (R) 5-ASA SUPPOSITORIES - 250MGStatus since Sep 2006 | 02112752 | Cancelled Post Market | |
| URSOFALKStatus since Aug 2000 | 01945254 | Cancelled Post Market | |
| VIOKASE POWDERStatus since Nov 2008 | 02230020 | Cancelled Post Market |
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| ULTRASE®Licensed Apr 2009 | 02203324 | Discontinued | |
| ULTRASE MT20Licensed Apr 2009 | 02045869 | Discontinued | |
| VIOKASELicensed Apr 2009 | 02230019 | Discontinued | |
| VIOKASELicensed Apr 2009 | 02241933 | Discontinued | |
| ULTRASE® MT12Licensed Apr 2009 | 02045834 | Discontinued |
Notices of Compliance
Newest first.
- URSO; URSO DSJuly 27, 2011 · NOC 12512 · Supplement to a New Drug Submission (SNDS)
- SALOFALKMay 2, 2011 · NOC 12301 · Supplement to a New Drug Submission (SNDS)
- SALOFALKMay 2, 2011 · NOC 12302 · Supplement to a New Drug Submission (SNDS)
- SALOFALKMay 2, 2011 · NOC 12303 · Supplement to a New Drug Submission (SNDS)
- PYLERAJanuary 4, 2011 · NOC 11982 · Supplement to a New Drug Submission (SNDS)
- URSO; URSO DSMay 5, 2005 · NOC 6656 · Supplement to a New Drug Submission (SNDS)
- SULCRATE; SULCRATE SUSPENSION PLUSFebruary 2, 2004 · NOC 169 · New Drug Submission (NDS)
- HELIZIDESeptember 5, 2003 · NOC 162 · Supplement to a New Drug Submission (SNDS)
- HELICIDEMarch 14, 2003 · NOC 229 · New Drug Submission (NDS)
- PHOTOFRINMarch 14, 2003 · NOC 3472 · Supplement to a New Drug Submission (SNDS)
- URSO DSSeptember 9, 2002 · NOC 813 · Supplement to a New Drug Submission (SNDS)
- URSOJune 19, 2002 · NOC 814 · Supplement to a New Drug Submission (SNDS)
- URSO TABLETSJanuary 30, 2001 · NOC 2598 · Supplement to a New Drug Submission (SNDS)
- PHOTOFRINJune 12, 2000 · NOC 1407 · New Drug Submission (NDS)
- SALOFALKMay 3, 2000 · NOC 1316 · Supplement to a New Drug Submission (SNDS)
- URSONovember 1, 1998 · NOC 3153 · Supplement to a New Drug Submission (SNDS)
- SALOFALKAugust 6, 1998 · NOC 2673 · Supplement to a New Drug Submission (SNDS)
- COPTINNovember 17, 1997 · NOC 4095 · New Drug Submission (NDS)
- MODULONOctober 24, 1997 · NOC 4119 · New Drug Submission (NDS)
- RECTOVALONEOctober 21, 1997 · NOC 4116 · New Drug Submission (NDS)
- URSOFALKAugust 12, 1997 · NOC 4098 · New Drug Submission (NDS)
- SALOFALKJuly 15, 1994 · NOC 5390 · New Drug Submission (NDS)
- SALOFALKJuly 15, 1994 · NOC 5391 · New Drug Submission (NDS)
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- SALOFALK 500mg: tablets may show black spots due to the oxidation of the active ingredient.April 24, 2025 · Drugs · Product quality · Type II